Literature DB >> 16806902

The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA).

Michael Baum1, Barrie R Cassileth, Rosy Daniel, Edzard Ernst, Jacqueline Filshie, Gerd Arno Nagel, Markus Horneber, Michelle Kohn, Stéphane Lejeune, Jane Maher, Risberg Terje, Wendy B Smith.   

Abstract

Patients diagnosed with breast cancer have many needs that for a start include the expectation of cure. Where cure is unlikely there is always a place for hope and spiritual support. Furthermore whether dealing with the early stages or with the advanced disease patients require symptomatic control that encompasses pain relief, control of nausea and vomiting and psychological distress. To achieve all of these goals there is a need that goes beyond the role of scientific medicine. This position papers describes the guidelines for the use of complimentary and alternative medicine (CAM) developed by a workshop on behalf of the European Society of Mastology (EUSOMA).

Entities:  

Mesh:

Year:  2006        PMID: 16806902     DOI: 10.1016/j.ejca.2006.02.019

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Complementary/alternative medicine for supportive cancer care: development of the evidence-base.

Authors:  E Ernst; M H Pittler; B Wider; K Boddy
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.603

2.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

3.  Complementary and alternative medicine use among patients with thyroid cancer.

Authors:  Jennifer E Rosen; Paula Gardiner; Robert B Saper; Amanda C Filippelli; Laura F White; Elizabeth N Pearce; Rebecca L Gupta-Lawrence; Stephanie L Lee
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

4.  Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. huebner@med.uni-frankfurt.de.

Authors:  J Huebner; M Follmann
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-02       Impact factor: 4.553

5.  Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.

Authors:  Güthlin Corina; Holmberg Christine; Gudrun Klein
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603

6.  A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.

Authors:  Nadja Klafke; Cornelia Mahler; Cornelia von Hagens; Justine Rochon; Andreas Schneeweiss; Andreas Müller; Hans-Joachim Salize; Stefanie Joos
Journal:  Trials       Date:  2015-02-15       Impact factor: 2.279

7.  Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.

Authors:  Jan Axtner; Megan Steele; Matthias Kröz; Günther Spahn; Harald Matthes; Friedemann Schad
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

8.  A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study.

Authors:  Susanne Blödt; Nadine Mittring; Lena Schützler; Felix Fischer; Christine Holmberg; Markus Horneber; Adele Stapf; Claudia M Witt
Journal:  BMC Cancer       Date:  2016-11-04       Impact factor: 4.430

9.  Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.

Authors:  Mascha de Kok; Caroline N A Frotscher; Trudy van der Weijden; Alfons G H Kessels; Carmen D Dirksen; Cornelis J H van de Velde; Jan A Roukema; Antoine V R J Bell; Fred W van der Ent; Maarten F von Meyenfeldt
Journal:  BMC Cancer       Date:  2007-07-02       Impact factor: 4.430

10.  The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment.

Authors:  Shiao Li Oei; Anja Thronicke; Matthias Kröz; Cornelia Herbstreit; Friedemann Schad
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-27       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.